• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡维地洛漂浮微球作为胃滞留型药物传递系统:3(2)完全因子设计及体外评价。

Floating microspheres of carvedilol as gastro retentive drug delivery system: 3(2) full factorial design and in vitro evaluation.

机构信息

University College of Pharmacy, Mahatma Gandhi University, Ettumanoor , Kerala , India .

出版信息

Drug Deliv. 2014 Mar;21(2):110-7. doi: 10.3109/10717544.2013.834414. Epub 2013 Sep 12.

DOI:10.3109/10717544.2013.834414
PMID:24028280
Abstract

CONTEXT

Designing a sustained release system for Carvedilol to increase its residence time in the stomach.

OBJECTIVE

Preparation of floating microsphere by the emulsion solvent diffusion method, studying the effect of various process parameters and optimize the formulation using full factorial design.

METHODS

Different microsphere formulations were prepared by varying the ratio ethanol:dichloromethane (1:0 to 1:1.5), ethyl cellulose:hydroxypropyl methyl cellulose and stirring speed (800-1600 rpm). The effect of these variables on particle size, encapsulation parameters, surface topography, in vitro floatability and drug release were evaluated.

RESULTS

3(2) full factorial design was used for the optimization of the formulation. Drug entrapment efficiency, particle size and in vitro drug release were dependent on concentration of ethyl cellulose and stirring speed. Microspheres remained buoyant for more than 10 h and showed sustained release of the drug.

CONCLUSION

Floating microspheres of Carvedilol with good floating ability and sustained release were developed.

摘要

背景

设计一种卡维地洛的缓释系统,以增加其在胃中的驻留时间。

目的

采用乳化溶剂扩散法制备漂浮微球,通过全因子设计研究各种工艺参数的影响,并优化处方。

方法

通过改变乙醇:二氯甲烷(1:0 至 1:1.5)、乙基纤维素:羟丙基甲基纤维素的比例和搅拌速度(800-1600 rpm)来制备不同的微球配方。评估这些变量对粒径、包封参数、表面形貌、体外漂浮性和药物释放的影响。

结果

采用 3(2)全因子设计对处方进行优化。药物包封效率、粒径和体外药物释放均依赖于乙基纤维素的浓度和搅拌速度。微球具有良好的漂浮能力,能在 10 小时以上保持漂浮,并呈现出药物的持续释放。

结论

制备了具有良好漂浮能力和持续释放性能的卡维地洛漂浮微球。

相似文献

1
Floating microspheres of carvedilol as gastro retentive drug delivery system: 3(2) full factorial design and in vitro evaluation.卡维地洛漂浮微球作为胃滞留型药物传递系统:3(2)完全因子设计及体外评价。
Drug Deliv. 2014 Mar;21(2):110-7. doi: 10.3109/10717544.2013.834414. Epub 2013 Sep 12.
2
Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.卡维地洛海藻酸钠粘膜粘附微球的研制、优化及鼻腔给药的体外评价。
J Microencapsul. 2009 Aug;26(5):432-43. doi: 10.1080/02652040802456726.
3
Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.用于鼻内给药的卡维地洛固体脂质纳米粒的研发、优化与评价
AAPS PharmSciTech. 2016 Dec;17(6):1353-1365. doi: 10.1208/s12249-015-0440-8. Epub 2016 Jan 7.
4
Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.载有卡维地洛纳米混悬剂的黏膜黏附型颊膜的配方与评价:一种用于传递高首过代谢药物的潜在方法。
Drug Deliv. 2013 Jun-Jul;20(5):224-35. doi: 10.3109/10717544.2013.779331. Epub 2013 May 8.
5
In vitro and in vivo evaluation of gastro-retentive carvedilol loaded chitosan beads using Gastroplus™.使用Gastroplus™对载有卡维地洛的胃滞留壳聚糖微球进行体外和体内评价。
Int J Biol Macromol. 2017 Sep;102:642-650. doi: 10.1016/j.ijbiomac.2017.04.067. Epub 2017 Apr 20.
6
Preparation, characterization and evaluation of ranitidine hydrochloride-loaded mucoadhesive microspheres.盐酸雷尼替丁载药黏膜黏附微球的制备、表征及评价
Polim Med. 2014 Apr-Jun;44(2):75-81.
7
Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.制备新型转基因生物/丙烯酸树脂E100纳米结构以提高卡维地洛的口服生物利用度。
Drug Dev Ind Pharm. 2016 Aug;42(8):1300-7. doi: 10.3109/03639045.2015.1128440. Epub 2016 Jan 6.
8
Preparation and characterization of floating drug delivery system of azithromycin.阿奇霉素胃漂浮型给药系统的制备与表征
Acta Pol Pharm. 2012 May-Jun;69(3):515-22.
9
Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa.左旋多巴/卡比多巴控释漂浮微球制备变量的评估与优化
Pharmazie. 2010 Mar;65(3):194-8.
10
Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.西咪替丁漂浮微球:制剂、表征及体外评价
Acta Pharm. 2005 Sep;55(3):277-85.

引用本文的文献

1
Probing the effect of various lipids and polymer blends on clopidogrel encapsulated floating microcarriers.研究各种脂质和聚合物共混物对氯吡格雷包封漂浮微载体的影响。
Daru. 2019 Dec;27(2):571-582. doi: 10.1007/s40199-019-00285-0. Epub 2019 Jun 21.
2
Enhanced gastric retention and drug release development of novel floating microspheres based on Eudragit E100 and polycaprolactone: synthesis and evaluation.基于聚丙烯酸树脂E100和聚己内酯的新型漂浮微球的胃滞留和药物释放增强研究:合成与评价
Des Monomers Polym. 2017 May 10;20(1):419-433. doi: 10.1080/15685551.2017.1326702. eCollection 2017.
3
Formulation development, optimization, and evaluation of sustained release tablet of valacyclovir hydrochloride by combined approach of floating and swelling for better gastric retention.
盐酸伐昔洛韦分散片的漂浮和溶胀相结合的方法进行制剂开发、优化和评价,以实现更好的胃滞留。
Drug Deliv Transl Res. 2014 Dec;4(5-6):452-64. doi: 10.1007/s13346-014-0207-x.